Assignee
JIANGSU KANIONREAL BIOMEDICAL TECH CO LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
4 records- 0154US2024124852A1Recombinant newcastle disease virus rndv-vegf-trap, genome thereof, preparation method therefor, and use thereofJIANGSU KANIONREAL BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0250US2024261371A1Rhfgf21 fusion protein, polynucleotide encoding rhfgf21 fusion protein, composition containing rhfgf21 fusion protein, and use of rhfgf21 fusion proteinJIANGSU KANIONREAL BIOMEDICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0346US2023203454A1Recombinant newcastle disease virus and preparation method therefor, recombinant plasmid, and use thereofJIANGSU KANIONREAL BIOMEDICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0446US2024271106A1Recombinant newcastle disease virus and preparation method therefor, recombinant plasmid, and use thereofJIANGSU KANIONREAL BIOMEDICAL TECH CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JIANGSU KANIONREAL BIOMEDICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →